Nouscom
PrivateLast Round
Series C
Mar 21, 2024
Total Funding Raised
$226.6M
Momentum Score
25 /100
Company Overview
Nouscom is a biotechnology company specializing in immunotherapy solutions that develop engineered viral vector vaccines for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nouscom Comps
Public and private peers based on sector, stage, and business model.
Nouscom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 21, 2024 | ||||
| Series C | Nov 14, 2023 | ||||
| Series B | Nov 6, 2017 | ||||
| Series A | May 17, 2016 |
Key People
Founding team and executive leadership
Nouscom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series C, Series B, Series A |
| XGEN Venture | Series C |
| Andera Partners | Series C |
| M Ventures | Series C |
| Indaco Venture Partners SGR | Series C |
| Bpifrance | Series C |
| 5AM Ventures | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2023
$82M round raised
Nouscom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nouscom's valuation, stock price, and market status.
